Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study. (4th August 2020) - Rivera, R.; Martorell, A.; López, A.; Salgado, L.; Sahuquillo, A.; de la Cueva, P.; Herranz, P.; Ratón, J.A.; Ferrán, M.; Izu, R.; Ruiz‐Genao, D.; García‐Donoso, C.; et al.